Morocco’s sweeping pharmaceutical pricing reform
Morocco is set to implement a major reform to its Drug Pricing Decree in the coming weeks.
Pricing and Market Access
Trade-offs abound as big pharma makes direct-to-consumer transition
Lilly first to opt for confidential reimbursement price in Germany
Pharma braces for critical French drug pricing reforms pending CEPS’s report
Navigating tariffs and diplomacy: the future of India-US pharmaceutical trade
The European Market Access Lag: 2021–2024
Trump revives plan for IRP use in US via MFN executive order
Next-generation targeting for evolving HCP engagement
